Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy
- 1 August 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (2) , 457-469
- https://doi.org/10.1016/s0002-9440(10)63311-1
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- A central role for inflammation in the pathogenesis of diabetic retinopathyThe FASEB Journal, 2004
- Is diabetic retinopathy an inflammatory disease?British Journal of Ophthalmology, 2002
- Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in VivoPublished by Elsevier ,2002
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1Journal of Biological Chemistry, 2001
- Advanced glycation end products increase retinal vascular endothelial growth factor expression.Journal of Clinical Investigation, 1998
- The Mouse Gene for Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.Journal of Clinical Investigation, 1993
- Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.BMJ, 1992
- A Follow-up Study of Vascular Disease in Growth-Hormone-Deficient Dwarfs with DiabetesNew England Journal of Medicine, 1978